Finance

Lists
0A9W:LON
Organon & Co
USD 13,77
-0,15%
(-0,020) 1D
13 Okt., 16:24:25 GMT+1  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for 0A9W...
Open
USD 13,78
High
USD 13,78
Low
USD 13,77
Mkt. cap
3,62 mjd
Avg. vol.
3,82 k
Volume
443,00
52-wk high
USD 13,84
52-wk low
USD 5,72
No. of employees
10 k
Open
USD 13,78
High
USD 13,78
Low
USD 13,77
Mkt. cap
3,62 mjd
Avg. vol.
3,82 k
Volume
443,00
52-wk high
USD 13,84
52-wk low
USD 5,72
No. of employees
10 k
News stories
From web sources and news partners
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 k
Founded1923
HeadquartersJersey City, New Jersey, Verenigde State van Amerika
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,60 mjd
1,51 mjd
1,46 mjd
1,56 mjd
Cost of goods sold
733,00 m
741,00 m
670,00 m
711,00 m
Cost of revenue
733,00 m
741,00 m
670,00 m
711,00 m
Research and development expenses
84,00 m
91,00 m
93,00 m
90,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
415,00 m
431,00 m
424,00 m
434,00 m
Operating expense
499,00 m
522,00 m
517,00 m
524,00 m
Total operating expenses
1,23 mjd
1,26 mjd
1,19 mjd
1,24 mjd
Operating income
370,00 m
244,00 m
273,00 m
323,00 m
Other non operating income
30,00 m
-18,00 m
15,00 m
-3,00 m
EBT including unusual items
243,00 m
-148,00 m
213,00 m
183,00 m
EBT excluding unusual items
255,00 m
103,00 m
170,00 m
210,00 m
Income tax expense
83,00 m
57,00 m
67,00 m
75,00 m
Effective tax rate
34,16%
-38,51%
31,46%
40,98%
Other operating expenses
-
-
-
-
Net income
160,00 m
-205,00 m
146,00 m
108,00 m
Net profit margin
9,99%
-13,60%
10,00%
6,93%
Earnings per share
1,01
0,63
0,71
0,85
Interest and investment income
-
-
-
-
Interest expense
-128,00 m
-121,00 m
-111,00 m
-108,00 m
Net interest expenses
-128,00 m
-121,00 m
-111,00 m
-108,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
462,00 m
340,00 m
359,00 m
403,00 m
Gain or loss from assets sale
-
-
-81,00 m
-
AI content may include mistakes. Learn more
Google-programme